Skip to main content
logo
Outlook Therapeutics, Inc. (OTLK)
NASDAQ: OTLK · Real-Time Price · USD
0.6400
+0.0310 (5.09%)
At close: Aug 25, 2026, 4:00 PM EDT
0.6433
+0.0033 (0.52%)
After-hours: Aug 25, 2026, 7:58 PM EDT

Outlook Therapeutics Cash Flow Statement

Millions USD. Fiscal year is Oct - Sep.

Operating Activities

Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '25 Sep '24 Sep '23 Sep '22 Sep '21
Net Income
-62.42-75.37-58.98-66.05-53.16
Depreciation & Amortization
0.120.110.040.20.26
Loss (Gain) on Equity Investments
0.140.10.010.050.05
Stock-Based Compensation
8.95.395.557.714.89
Other Operating Activities
-4.973.995.653.10.79
Change in Accounts Receivable
-1.49----
Change in Inventory
-3.34----
Change in Accounts Payable
1.671.393.081.3-0.2
Change in Other Net Operating Assets
9.58-4.411.67-2.98-6.88
Operating Cash Flow
-51.83-68.79-42.97-56.67-54.25
Operating Cash Flow Growth
-----

Financing Activities

Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '25 Sep '24 Sep '23 Sep '22 Sep '21
Long-Term Debt Issued
33.1-301010
Long-Term Debt Repaid
-36.14-0-10.23-12.32-3.69
Net Debt Issued (Repaid)
-3.04-019.77-2.326.31
Issuance of Common Stock
48.0360.3330.0262.5149.9
Other Financing Activities
---0.82-0.6-0.01
Financing Cash Flow
44.9860.3348.9759.5956.19

Net Cash Flow

Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '25 Sep '24 Sep '23 Sep '22 Sep '21
Net Cash Flow
-6.84-8.4662.921.94

Free Cash Flow

Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '25 Sep '24 Sep '23 Sep '22 Sep '21
Free Cash Flow
-51.83-68.79-42.97-56.67-54.25
Free Cash Flow Growth
-----
Free Cash Flow Margin
-3666.65%----
Free Cash Flow Per Share
-1.49-3.71-3.44-5.34-7.11
Levered Free Cash Flow
-27.15-44.3-24.26-32.53-35.62
Unlevered Free Cash Flow
-26.97-42.33-22.68-31.6-35.03

Additional Metrics

Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '25 Sep '24 Sep '23 Sep '22 Sep '21
Cash Interest Paid
-0.481.161.560.05
Change in Working Capital
6.41-3.024.75-1.68-7.08
SEC Filings: 10-K · 10-Q